샤페론

378800KOSDAQSector: Pharma & Biotech

₩518▲ 0.78%Market cap ₩24.0BAs of Jul 21, 2026 close · updated once daily

Grade C48.3 ptsTop 57% of 2,523 stocksPreviously B

Financial strength

47.3

Growth momentum

70.6

Price attractiveness

33.4

As of Jul 21, 2026 close · This grade is not a buy/sell recommendation — it is information mechanically scored from public data using a fixed formula.

Financial strength

47.3

How much debt does it carry relative to equity?

Debt-to-equity ratio

12.7%

✓ Above median · Top 14.4% in sector

Sector median 51.5%

Can it cover what's due within a year?

Current ratio

1253.4%

✓ Above median · Top 12% in sector

Sector median 191.3%

How much of revenue becomes profit?

Operating margin

-6952.9%

✗ Below median · Top 97.3% in sector

Sector median -2.3%

How much did it earn on its own capital?

ROE (return on equity)

-62.8%

✗ Below median · Top 87.2% in sector

Sector median -4.5%

Source filing: annual report (consolidated) — view original ↗

Growth momentum

70.6

How much did revenue grow in a year?

Revenue growth (YoY)

1186.7%

✓ Above median · Top 1.1% in sector

Sector median 6.4%

Did core profits grow in a year?

Operating income change (YoY)

-4.6%

✗ Below median · Top 57.8% in sector

Sector median 3.6%

Source filing: annual report (consolidated) — view original ↗

Price attractiveness

33.4

Is the price expensive relative to earnings?

P/E (price-to-earnings)

Loss-making (P/E not computable)

✗ Below median · Top 94.1% in sector

Sector median P/E of profitable peers 14.4x · 57% loss-making

Is the price expensive relative to book value?

P/B (price-to-book)

0.97x

✓ Above median · Top 39.2% in sector

Sector median 1.39x

Valuation uses the Jul 21, 2026 close and market cap

Grade distribution of 248 stocks in Pharma & Biotech

S1A52B66C51D61F15